48
total announcements
544135.BO · 15 min delayed
Mukka Proteins Ltd
Mukka Proteins Ltd announced an investor presentation for Q2 & FY27, highlighting its unaudited financial results and business update.
Mukka Proteins Ltd
Mukka Proteins Ltd has announced the newspaper publication of its unaudited financial results for the half year and six months period ended 30th September 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mukka Proteins Ltd
Mukka Proteins Ltd reported strong Q2 FY27 performance with 108.06% YoY revenue growth, 157.51% YoY PAT growth, and improved EBITDA margin. The company's Oman facility commenced commercial production, and it received USDA NOP inputs attestation for Eco Sphere Organic Fertilizer. CARE Ratings revised the outlook to Stable from Negative.
Mukka Proteins Ltd
Mukka Proteins Ltd has revised the terms of its proposed investment in Swachha Eco Solutions Private Limited, acquiring 85,200 equity shares for Rs. 2,13,00,000, equivalent to 46% of the issued and paid-up equity share capital of the Investee Company.
Mukka Proteins Ltd
Mukka Proteins Ltd has announced its financial results for the quarter and half year ended 30th September 2026. The company's unaudited financial results (standalone and consolidated) are enclosed, along with the Limited Review Report received from the Statutory Auditors. The Board has also approved a revised investment in Swaccha Eco Solutions Private Limited (SESPL) by subscribing to 85,200 equity shares at ₹250/- per share, aggregating to a total investment of ₹2,13,00,000/-.
Mukka Proteins Ltd
Mukka Proteins Ltd has intimated a statement of deviation or variation in the utilization of funds raised through a preferential issue of warrants for the quarter ended 30th September 2026. The company has confirmed that there has been no deviation or variation in the utilization of proceeds of the preferential issue.
Mukka Proteins Ltd
Mukka Proteins Ltd's Board of Directors approved the unaudited financial results for the quarter and half year ended September 30, 2026, and revised the terms of investment in Swaccha Eco Solutions Private Limited (SESPL). The Board approved subscribing to 85,200 equity shares at ₹250 per share, aggregating to a total investment of ₹2,13,00,000, representing 46% of the paid-up capital, thereby making SESPL an associate of the Company.
Mukka Proteins Ltd
Mukka Proteins Ltd to consider and approve unaudited financial results for the quarter and half year ended 30th September 2026.
Mukka Proteins Ltd
Mukka Proteins Ltd has received a Certificate of Registration from Registrar Corp, Virginia, USA, confirming the registration of its facility with the U.S. Food and Drug Administration (U.S. FDA) pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act. This registration is expected to support the Company's business operations and facilitate its engagement with customers and markets requiring U.S. FDA facility registration.
Mukka Proteins Ltd
Mukka Proteins Ltd's overseas subsidiary, United Gulf Fishery Products LLC, has commenced commercial production of fish meal, fish oil, and fish soluble paste in Oman, expected to enhance production capacity and strengthen the company's presence in the Middle East market.
Mukka Proteins Ltd
Mukka Proteins Ltd has informed the exchange that its board has approved the provision of corporate guarantee, Standby Letter of Credit (SBLC), and security to secure the due repayment of certain credit facilities to be availed by its subsidiary, United Gulf Fishery Products LLC, Oman, from HDFC Bank Limited. The aggregate value of the credit facilities is up to Rs. 735,830,000. The relevant agreements/documents are yet to be executed.
Mukka Proteins Ltd
Mukka Proteins Ltd has received credit ratings from CARE Ratings Limited, with a long-term rating of CARE BBB- and a short-term rating of CARE A3. The ratings reflect the company's improved operating performance in Q1FY27, driven by rising global fish meal prices and steady demand.
Mukka Proteins Ltd
Mukka Proteins Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming that no demat requests were received for processing during the quarter ended 30th September 2026, as no shares of the company are in physical mode.
Mukka Proteins Ltd
Mukka Proteins Ltd has received a USDA NOP - Inputs Attestation from ECOCERT S.A.S., France, confirming its product 'Eco Sphere Organic Fertilizer' is suitable for use in organic farming, subject to specific conditions.
Mukka Proteins Ltd
Mukka Proteins Ltd has announced a delay in the acquisition of Aqua Marine, citing procedural issues. The expected completion date has been revised from September 30, 2026, to January 31, 2027.
Mukka Proteins Ltd
Mukka Proteins Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter and half year ending September 30, 2026.
Mukka Proteins Ltd
Mukka Proteins Ltd has rescheduled its analysts/investors meeting, originally planned for September 28, 2026, to September 29, 2026. The meeting will be held virtually with Suraag Capital. No unpublished price-sensitive information will be disclosed during the meeting.
Mukka Proteins Ltd
Mukka Proteins Ltd has announced an analyst/investor meeting on September 28, 2026, with Suraag Capital, and has stated that no unpublished price-sensitive information will be disclosed.
Mukka Proteins Ltd
Mukka Proteins Ltd has announced an analyst/investor meeting on September 25, 2026, with International Finance Corporation. The meeting will be held virtually and is a one-on-one meeting. The company has assured that no unpublished price-sensitive information will be disclosed.
Mukka Proteins Limited
Mukka Proteins Limited has informed BSE about the re-appointment of an Executive Director.